NCT00667069 2025-06-05
Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer
UNICANCER
Phase 3 Completed
UNICANCER
University College, London
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Radiation Therapy Oncology Group
UNICANCER
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)